<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117856">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02146469</url>
  </required_header>
  <id_info>
    <org_study_id>SH2012VAR</org_study_id>
    <nct_id>NCT02146469</nct_id>
  </id_info>
  <brief_title>Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine</brief_title>
  <official_title>Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Municipal Center for Disease Control and Prevention</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Institute Of Biological Products</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Municipal Center for Disease Control and Prevention</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is as follows:

        1. To know the antibody level during different interval after received 1 dose varicella
           vaccine.

        2. To know safety and effectiveness of received 2 doses varicella vaccine with different
           interval.

        3. To know safety and effectiveness of received varicella vaccine and MMR at the same
           time.

      To achieve that, this study selects children with specific varicella vaccine history, gives
      1 or 2 doses varicella vaccine, collects blood specimens and makes a follow-up visit after
      vaccination.

      All blood specimens will be tested by a third-party detection institution.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Seroconversion rate and GMCs after varicella vaccination</measure>
    <time_frame>35-42 days after each dose vaccination</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of Adverse Events Following Immunization</measure>
    <time_frame>30 days after each dose vaccination</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Varicella</condition>
  <arm_group>
    <arm_group_label>None varicella vaccine history</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 doses with an 3 months interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 year after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 1 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 years after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 3 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 years after first dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A second dose with an 5 year interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Testing group for conbined immunization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 dose Varicella vaccine and 1 dose MMR given at the same time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group for conbined immunization</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 dose MMR</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>2 doses with an 3 months interval</intervention_name>
    <description>varicella vaccination</description>
    <arm_group_label>None varicella vaccine history</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 1 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>1 year after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 3 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>3 years after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>A second dose with an 5 year interval</intervention_name>
    <description>varicella vaccine</description>
    <arm_group_label>5 years after first dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>1 dose Varicella vaccine and 1 dose MMR given at the same time</intervention_name>
    <description>varicella vaccine and MMR</description>
    <arm_group_label>Testing group for conbined immunization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>1 dose MMR</intervention_name>
    <description>MMR</description>
    <arm_group_label>Control group for conbined immunization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 1 to 7

          -  Without a previous history of varicella

          -  With an axillary temperature ≤37.5℃ at the time of vaccination

          -  Appropriate varicella vaccination history

          -  With guardian signing the informed consent and available for clinical observation

        Exclusion Criteria:

          -  Hypersensitive to any active substance of the vaccine including excipients and
             antibiotics

          -  With acute illness, severe or acute attack of chronic illness or fever

          -  With immunodeficiency or weakened immune system or being treated with
             immunosuppressant drugs

          -  Suffering a brain disease, uncontrolled epilepsy or progressive nerve system disease

          -  With a family or personal history of seizure, chronic illness, epilepsy or allergy

          -  With unknown immunization history or unable to follow the immunization schedule of
             EPI

          -  Received any vaccine  within 4 weeks or willing to receive any vaccine in 1 month

          -  With hemorrhagic tendency or prolonged period of bleeding

          -  Received whole blood, plasma or immunoglobulin within 5 months

          -  Received systemic antibiotics or antiviral treatment for acute illness within 7 days

          -  With an axillary temperature ≥38℃ within 3 days

          -  Participating in another clinical trial

          -  Any situation that might influence the consequence of the clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaodong Sun</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Municipal Center for Disease Control and Prevention</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai municipal center for disease control and prevention</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>May 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>varicella vaccination</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chickenpox</mesh_term>
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
